Eurepa 1 mg Tablet

Eurepa 1 mg Tablet is a prescription diabetes medicine that contains 1 mg of repaglinide in each tablet. It belongs to the meglitinide class of blood sugar-lowering drugs and is used to help control blood glucose in adults with type 2 diabetes. Eurepa 1 mg Tablet is taken by mouth and works around meal times to help reduce after-meal blood sugar spikes. It is not used to treat type 1 diabetes or diabetic ketoacidosis.

How it works: Repaglinide helps the pancreas release more insulin for a short time, especially right after you eat. As a tablet, Eurepa 1 mg Tablet is designed to be taken before meals so it can help control the rise in blood sugar that happens after eating.

Eurepa 1 mg Tablet is a standard strength that may be chosen when a doctor wants a modest repaglinide dose with flexible meal-based dosing. Because this is the only Eurepa strength sold in our range, it represents the available tablet option for patients who have been assessed to need repaglinide therapy. Some patients may start lower with a different repaglinide product or need a different tablet count based on their blood sugar response, so the exact regimen should be individualized.

• Type 2 diabetes blood sugar control
• Helps lower after-meal glucose spikes
• Part of a diabetes meal-plan and exercise routine
• May be used alone or with other diabetes medicines

• Swallow Eurepa 1 mg Tablet with water; do not crush or chew unless your doctor specifically tells you otherwise.
• Take it before meals, usually within 30 minutes before eating.
• If you skip a meal, skip the dose for that meal.
• Do not take an extra tablet to make up for a missed dose if you did not eat.
• Check your blood sugar as directed and follow the meal plan your doctor gives you.
• Carry a quick source of glucose in case of low blood sugar.

Each Eurepa 1 mg Tablet contains 1 mg of repaglinide. It is taken before meals, and the number of daily doses depends on how many meals you eat; your doctor decides the dose and schedule based on your blood sugar readings and response. The total daily dose should not exceed 16 mg per day.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Repaglinide may include:

• Low blood sugar (hypoglycemia), which may be more noticeable if you eat less than usual
• Headache
• Stomach pain
• Nausea
• Diarrhea
• Upper respiratory symptoms such as a stuffy nose or sore throat

• Take Eurepa 1 mg Tablet only if you are going to eat; skipping meals can raise the risk of hypoglycemia.
• Use caution if you drink alcohol, because it can make blood sugar harder to control.
• Tell your doctor if you have liver disease, because repaglinide may need extra caution.
• Be careful when driving or operating machinery until you know how this medicine affects your blood sugar.
• Let your doctor know about any history of heart disease, frequent low blood sugar, or kidney problems.
• Do not use this medicine for type 1 diabetes or diabetic ketoacidosis.

• Gemfibrozil can greatly increase repaglinide levels and is generally not used together with it.
• Other diabetes medicines, including insulin or sulfonylureas, can increase the risk of low blood sugar.
• Certain antibiotics, antifungals, and some other prescription drugs may change repaglinide levels.
• Alcohol can worsen blood sugar swings and increase the risk of hypoglycemia.

Store Eurepa 1 mg Tablet at room temperature in its original strip/box, away from moisture and heat.